Severe Systemic Fatigue: NAC's ability to break disulfide bonds in microclots helps restore proper capillary blood flow, ensuring that oxygen and nutrients can reach oxygen-starved muscle tissues, thereby reducing systemic exhaustion
A statistically significant improvement in KCCQ-CSS was found in the semaglutide group compared with placebo, although the magnitude of improvement was numerically smaller than in STEP-HFpEF
Notably, liraglutide (LEADER trial) and semaglutide (SUSTAIN-6 trial) have demonstrated cardiovascular benefits, including reductions in cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke
This has led to conceptualizing obesity as a chronic disease requiring ongoing management rather than a condition amenable to short-term cure
Aging adults experiencing a decline in muscle mass or strength
Pinna A, Zaccheddu F, Boscia F, Carru C, Solinas G